Drug Trial Radar · NCT07709897
A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting
Last checked: Nov 19, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
260
Planned (sponsor's estimate)
Start
Aug 6, 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the efficacy of HRS5580 for injection combined with palonosetron hydrochloride in the prevention of postoperative nausea and vomiting, and to explore the effective dose of HRS5580 for injection combined with palonosetron hydrochloride for the prevention of postoperative nausea and vomiting.
Conditions
- Prevention of Postoperative Nausea and Vomiting
Interventions
HRS5580 for injection combined with palonosetron hydrochloride;Drug
HRS5580 for injection combined with palonosetron hydrochloride; low dose
HRS5580 for injection combined with palonosetron hydrochlorideDrug
HRS5580 for injection combined with palonosetron hydrochloride; high dose
HRS5580 for injection blank preparation combined with palonosetron hydrochlorideDrug
HRS5580 for injection blank preparation combined with palonosetron hydrochloride
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete response rate within 72 hours after extubation (defined as the proportion of participants with no vomiting and no use of rescue therapy)Time frame: within 72 hours after extubation
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Fudan University Zhongshan Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Tianjin Nankai Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.